PE/Cyanine5.5 Anti-Human CD18 Antibody[TS1/18.1.2.11]

Introducing the PE/Cyanine5.5 Anti-Human CD18 Antibody [TS1/18.1.2.11], a highly advanced and meticulously developed product designed to cater to the specific needs of the scientific community. This antibody, meticulously crafted with precision and expertise, offers an exceptional solution for the detection and analysis of human CD18.

The PE/Cyanine5.5 Anti-Human CD18 Antibody [TS1/18.1.2.11] showcases unparalleled performance and reliability, making it an indispensable tool for researchers and scientists alike. Its cutting-edge formulation ensures optimal specificity and sensitivity, enabling accurate identification and characterization of CD18 in various experimental settings.

This antibody, meticulously validated through rigorous quality control measures, guarantees consistent and reproducible results, instilling confidence in experimental outcomes. Its exceptional binding affinity to human CD18 ensures minimal background noise, facilitating precise and reliable data interpretation.

The PE/Cyanine5.5 Anti-Human CD18 Antibody [TS1/18.1.2.11] is designed to seamlessly integrate into a wide range of applications, including flow cytometry, immunofluorescence, and immunohistochemistry. Its versatility allows for comprehensive exploration of CD18 expression patterns, enabling deeper insights into cellular processes and disease mechanisms.

Furthermore, this antibody is manufactured in strict adherence to the highest industry standards, ensuring utmost purity and consistency. Its long shelf life and stability guarantee prolonged usability, making it an economical choice for laboratories and research institutions.

In summary, the PE/Cyanine5.5 Anti-Human CD18 Antibody [TS1/18.1.2.11] represents a pinnacle of scientific innovation, offering an indispensable tool for the precise detection and analysis of human CD18. With its exceptional performance, reliability, and versatility, this antibody is poised to revolutionize research in the field, empowering scientists to unravel the complexities of CD18 biology and its implications in various pathological conditions.